Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 5/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5082404 | 0.87 | MEN1 (0.61) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL4015124 | 0.87 | MEN1 (0.61) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL13845797 | 0.77 | POLB (0.52) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL13845795 | 0.76 | MEN1 (0.55) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL13849822 | 0.75 | POLB (0.48) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL13845793 | 0.75 | POLB (0.55) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL16600839 | 0.75 | MEN1 (0.49) | KMT2AMEN1RAB9APOLBHTT | |
| SCHEMBL4674925 | 0.74 | GAA (0.63) | KMT2AMEN1POLBKDM4EMAPK1 | |
| SCHEMBL4077463 | 0.74 | GAA (0.63) | KMT2AMEN1POLBKDM4EMAPK1 | |
| SCHEMBL25243550 | 0.74 | MEN1 (0.71) | KMT2AMEN1RAB9APOLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7538245-B2 | Process for the manufacture of an enantiopure compound | SOLVAY S.A. (BE) | 2009-05-26 | — | — | US | disclosed |
| US-20080027211-A1 | Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments | SOLVAY S.A. (BE) | 2008-01-31 | — | — | US | disclosed |
| US-20070027326-A1 | Process for the manufacture of an enantiopure compound | SOLVAY S.A. (BE) | 2007-02-01 | — | — | US | disclosed |
| EP-1664084-A1 | PROCESS FOR THE MANUFACTURE OF AN ENANTIOPURE COMPOUND | SOLVAY (Société Anonyme) (BE) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005023838-A1 | PROCESS FOR THE MANUFACTURE OF AN ENANTIOPURE COMPOUND | Solvay (Société Anonyme) (BE) | 2005-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027211-A1 | Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments | NPR3, VIP, NPPA | KMT2A 4324/4885MEN1 206/4885RAB9A 3526/4885 |
| US-20070027326-A1 | Process for the manufacture of an enantiopure compound | AMD1, DAO, DDC | KMT2A 3516/4885MEN1 3808/4885RAB9A 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.